OB
SummitIn person
2nd Oligonucleotide-Based Therapeutics Summit
Hosted by Hanson Wade
- 8 – 10 December 2026
Add to calendar
Welcome to kongre.net - Aloft Boston Seaport District, Boston, United States of America
- Medical & Health SciencesEngineering & TechnologyBiomedical EngineeringBiological SciencesBiochemistry & Molecular Biology
Let others know you'll be there. This does not register you for the event.
Welcome to kongre.net
Welcome to kongre.net
Key facts
2nd Oligonucleotide-Based Therapeutics Summit is a summit held 8 – 10 December 2026 in Aloft Boston Seaport District, Boston, United States of America, organised by Hanson Wade.
- Dates:
- 8 – 10 December 2026
- Format:
- In person
- Venue:
- Aloft Boston Seaport District, Boston, United States of America
- Subjects:
- Medical & Health Sciences, Biomedical Engineering, Biochemistry & Molecular Biology
- Organiser:
- Hanson Wade
- Official website:
- oligonucleotide-based-therapeutics.com
The 2nd Oligonucleotide-Based Therapeutics Summit is a dedicated meeting for scientists advancing the next generation of oligonucleotide therapeutics, focusing on breakthroughs in delivery, chemistry, and translation. The event brings together leaders from across pharma and biotech for three days of technical discussion, data sharing, and networking.
Conference theme
Innovating Precision Delivery & Capturing Novel Chemistry
Objectives
Explore innovations in blood-brain barrier engineering, AI-designed miniproteins, novel conjugates, circular ASOs, and emerging chemistries to accelerate development and de-risk pipelines.
Who should attend
Scientists, researchers, and decision-makers in oligonucleotide chemistry, delivery, platform discovery, and translational science across pharma and biotech.
Organising Committee
Mayra Katsimantis - Program Director
Nisha Poyser-Reid - Senior Marketing Manager
Freya Hitchcock - Delegate Audience Manager
Tazeen Kapadia - Partnerships Director
Grace Gleadell - Event Manager
Programme highlights
View full programmeSpeakers
View all 9 speakersUniversity of Massachusetts Medical School
Enabling Targeted Muscle Delivery Through Aptamer-siRNA Conjugates Beyond Antibody Conjugates +1 moreUniversity of Massachusetts Medical School
Advancing Precision RNAi for Fibrodysplasia Ossificans Progressiva Through a Combinatorial, Unimolecular, Allele-Selective Approach
Organiser and contact
Contact
- Email:
- [email protected]
Advertisement
Related events
- 53rd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium)New York, United States of America17–21 Nov 2026
- ASTMH 2026 Annual MeetingNational Harbor, United States of America18–22 Nov 2026
- International Kidney Cancer Symposium (IKCS): North America 2026Dallas, United States of America19–21 Nov 2026
- The 14th Congress on Reproductive Health and InfertilityAntalya, Türkiye19–22 Nov 2026
- 16th National and 2nd International Congress on Medical Education (UTEK 2026)Kahramanmaraş, Türkiye19–22 Nov 2026
- 5th International Congress on Sports, Anthropology, Nutrition, Anatomy and Radiology (SANAR2026)Niğde, Türkiye19–21 Nov 2026